The therapeutic target of estrogen receptor-alpha36 in estrogen-dependent tumors

J Transl Med. 2014 Jan 21:12:16. doi: 10.1186/1479-5876-12-16.

Abstract

Estrogen receptor-alpha36 (ER-α36) is a new isoform of estrogen receptors without transcriptional activation domains of the classical ER-α(ER - α66). ER-α36 is mainly located in cytoplasm and plasma membrane. ER-α36 mediates non-genomic signaling and is involved in genomic signaling of other ERs. Recently ER-α36 is found to play a critical role in the development of estrogen-dependent cancers and endocrine resistance of breast cancer. The present article overviews and updates the biological nature and function of ER-α36, potential interaction of ER-α36 with other estrogen receptors and growth factor receptors, intracellular signaling pathways, potential mechanism by which ER-α36 may play an important role in the development of tumor resistance to endocrine therapies.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Estrogen Receptor alpha / chemistry
  • Estrogen Receptor alpha / metabolism*
  • Estrogens / metabolism*
  • Humans
  • Intercellular Signaling Peptides and Proteins / metabolism
  • Molecular Targeted Therapy*
  • Neoplasms / enzymology
  • Neoplasms / metabolism*
  • Neoplasms / pathology
  • Neoplasms / therapy*
  • Protein Kinases / metabolism

Substances

  • Estrogen Receptor alpha
  • Estrogens
  • Intercellular Signaling Peptides and Proteins
  • Protein Kinases